Single GLP-1 Receptor Agonists: Semaglutide (brand names Wegovy, Ozempic) Liraglutide (Saxenda) Dual GLP-1/GIP Receptor Agonists: Tirzepatide (brand names Zepbound, Mounjaro) Recent comprehensive research comparing these options has revealed striking differences in effectiveness
Ozempic has garnered a great deal of mainstream attention as a medication for supporting weight loss, but its often overlooked as a potential addition to a diabetes management plan
He is an advisor to Temedica GmbH, a patient-oriented data generation company
The patients on liraglutide had already achieved approximately 12% weight loss
Equally the majority of the population thought they were not interested in using the medications, and while attitudes may change, as with other medical interventions this might suggest limits on public willingness to use them
J Mol Biol 432(5):13261346